Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trichuris Suis Ova for Moderate to Severe Chronic Plaque Psoriasis
NCT02011269Phase 2Withdrawn
- Sponsor
- Fortress Biotech
- Start
- Mar 2014
- Primary completion
- Jan 2015
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of trichuris suis ova in plaque psoriasis, sponsored by Fortress Biotech. Planned start Mar 2014; status: withdrawn.
02
Drugs
trichuris suis ova
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02011269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011269.